Social Media Discussions on Meds Give Rise to “Patient Influencers”
To better understand the new phenomenon of “patient influencers”, the authors conducted interviews with individuals who routinely offer advice on health topics on social media.
To better understand the new phenomenon of “patient influencers”, the authors conducted interviews with individuals who routinely offer advice on health topics on social media.
A new practice guideline for the treatment of patients with eating disorders.
Researchers evaluated clinical trial data and drug databases to provide updated recommendations on antimicrobial dosing for patients with obesity.
The SURMOUNT-1 trial evaluated tirzepatide as an adjunct to a reduced-calorie diet and increased physical activity in adults without type 2 diabetes who have obesity or are overweight.
Six organizations that focus on the diagnosis and treatment of obesity have released a consensus statement to reduce barriers to care.
Researchers sought to determine whether fecal microbiota transplantation from a lean donor contributes to an improvement in bariatric surgery outcomes.
Obesity experts discuss the cost of newer obesity medications (eg, GLP-1 agonists) and access issues, including Ozempic shortages.
Sibutramine is a controlled substance that was voluntarily withdrawn from the market in October 2010.
Researchers conducted a study to assess the long-term effects of COVID-19 infection in comparison with other common respiratory viral infections.
Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist.